These therapies aim to enhance WL and improve metabolic outcomes by engaging multiple hormonal pathways, with preclinical and early-phase clinical trials supporting their potential as next-generation obesity treatments [16,17,18,19,20,21,22,23]
Two key enzymes, ADH (alcohol dehydrogenase) and ALDH (aldehyde dehydrogenase), are responsible for metabolizing alcohol, by helping to break down alcohol molecules into smaller parts that can then be eliminated
10.1080/13547500400024768 Biomarkers
Ethics declarations Conflict of interest P.S.S
Effect of human growth hormone-releasing hormone on GH secretion in Cushings syndrome and non-endocrine disease patients treated with glucocorticoids
Lipoyl deglutarylation by ABHD11 regulates mitochondrial and T cell metabolism